[Perioperative heparin bridging is rarely indicated]

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• Warfarin therapy requires careful management during surgical procedures.
• Heparin bridging is a common practice to prevent thromboembolism in patients on warfarin.
• Existing evidence suggests potential risks associated with heparin bridging.

Purpose of the Study:

• To critically evaluate the efficacy and safety of perioperative heparin bridging.
• To determine when heparin bridging is unnecessary or when prophylactic dosing is sufficient.
• To identify conditions where therapeutic heparin dosing may be safely considered.

Main Methods:

• Analysis of meta-analyses of cohort studies.
• Review of a recent randomized, placebo-controlled trial on heparin bridging.
• Synthesis of evidence regarding bleeding and thromboembolic events.

Main Results:

• Perioperative heparin bridging with therapeutic doses increases major bleeding risks multi-fold.
• Therapeutic heparin bridging does not reduce the incidence of thromboembolism.
• Current practices of heparin bridging warrant reconsideration.

Conclusions:

• The routine use of therapeutic heparin bridging in warfarin patients undergoing surgery is associated with increased bleeding without proven benefit.
• Clinical guidelines should be updated to reflect the risks and benefits of heparin bridging.
• Further research may clarify optimal strategies for managing anticoagulation around procedures.